Clinical Trials Browser

Completed × OTHER × Pharmacokinetics × Clear all

NCT02120222 2023-04-04

KPT-330

Phase 1 Completed

Melanoma

NCT00989586 2017-02-06

Veltuzumab and Milatuzumab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma

Phase 1/2 Completed

35 enrolled 11 charts

Lymphoma, Lymphoma, Follicular, Waldenstrom Macroglobulinemia, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell

NCT00323323 2017-01-20

CHOP and Campath-1H in Previously Untreated Aggressive T/NK-Cell Lymphomas

Phase 1 Completed

Lymphoma, Non-Hodgkin